Corporate Banner
Satellite Banner
Technology Networks Header
Monday, December 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
PSE Releases Major Update of gCRYSTAL Process Modelling Software
Thursday, June 21, 2012
Leading batch operation tool now guides batch-to-continuous R&D and Engineering efforts.

The University of Dundee chooses Rigaku X-ray diffraction (XRD) instruments for research into protein structure determination
Friday, June 15, 2012
X-ray crystallography facility updated with fully automated protein crystallography system

A Simple, Cost-Effective Route to Parallel Crystallization
Thursday, June 07, 2012
DrySyn heating block system is designed by Asynt in conjunction with the University of Bath.

Sub-ambient Reaction Systems for Crystallization Studies
Monday, May 28, 2012
Asynt DrySyn® SnowStorm systems perfect for crystallization studies and screening polymorphs.

High-Throughput and High-Salt Measurements of Electrophoretic Mobility with Wyatt’s Möbius
Friday, February 17, 2012
Wyatt to showcase Möbius™, its innovative zeta potential instrument at PITTCON 2012.

Labcyte Advances Automatic Acoustic Liquid Handling With Dynamic Fluid Analysis™
Tuesday, February 07, 2012
The company has patented and released a novel software algorithm that enables a greater range of fluid types to be automatically transferred with acoustic energy.

New Vibration Free Incubator Ideal for Protein Crystallography
Monday, February 06, 2012
Peltier-based incubators for heating and chilling.

Rigaku Introduces New 5th Generation MiniFlex Benchtop XRD Instrument
Tuesday, January 17, 2012
New 5th generation MiniFlex performs qualitative and quantitative analysis of polycrystalline materials.

Agilent’s Diffractometer is Centerpiece of New Structural Biology Lab at Budapest Technical University
Friday, December 02, 2011
Researchers publish first paper just three months after instrument installed.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 233
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn